Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hannelouise Kissow
Observed names:
H KISSOW,
H Kissow,
H. Kissow,
H.L Kissow,
Hanne-Louise Kissow,
Kissow, Hannelouise
show all 6
Institutions:
University of Copenhagen,
Novo Nordisk Foundation Center for Basic Metabolic Research
Observed institutions:
University of Copenhagen,
Novo Nordisk (Denmark),
Novo Nordisk Foundation,
Danish National Research Foundation,
Novo Nordisk Foundation Center for Basic Metabolic Research
ORCID:
0000-0001-9351-8885
Observed ORCID:
0000-0001-9351-8885
OpenAlex ID:
A5046035975
Works
70
Awards
1
Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow
2015
·
Elisa P. Jensen
, Steen S. Poulsen
, et al.
·
American Journal of Physiology-Renal Physiology
·
146
Glucagon-Like Peptide-1 (GLP-1) Reduces Mortality and Improves Lung Function in a Model of Experimental Obstructive Lung Disease in Female Mice
2013
·
Niels-Erik Viby
, Marie S. Isidor
, et al.
·
Endocrinology
·
134
Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice
2004
·
J Thulesen
, B Hartmann
, et al.
·
Gut
·
124
PDF
Dipeptidyl Peptidase IV Inhibition Enhances the Intestinotrophic Effect of Glucagon-Like Peptide-2 in Rats and Mice
2000
·
B. Hartmann
, J. Thulesen
, et al.
·
Endocrinology
·
123
Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis
2017
·
Katrine D. Galsgaard
, Marie Winther-Sørensen
, et al.
·
American Journal of Physiology-Endocrinology and Metabolism
·
118
Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice
2012
·
Hannelouise Kissow
, Bolette Hartmann
, et al.
·
Regulatory Peptides
·
99
The truncated metabolite GLP-2 (3–33) interacts with the GLP-2 receptor as a partial agonist
2002
·
Jesper Thulesen
, Lotte Bjerre Knudsen
, et al.
·
Regulatory Peptides
·
90
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial
2019
·
Rahim M Naimi
, Mark Hvistendahl
, et al.
·
The Lancet. Gastroenterology & hepatology
·
78
GLP-1 and Intestinal Diseases
2021
·
Jenna Elizabeth Hunt
, Jens Juul Holst
, et al.
·
Biomedicines
·
68
PDF
Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis
2012
·
Hannelouise Kissow
, Bolette Hartmann
, et al.
·
Gut
·
67
Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat
2004
·
Steen Seier Poulsen
, Hannelouise Kissow
, et al.
·
Regulatory Peptides
·
67
Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats
2002
·
Bolette Hartmann
, Jesper Thulesen
, et al.
·
Regulatory Peptides
·
66
Why is it so difficult to measure glucagon-like peptide-1 in a mouse?
2017
·
Johanne A. Windeløv
, Nicolai J. Wewer Albrechtsen
, et al.
·
Diabetologia
·
63
PDF
Intestinal Growth Adaptation and Glucagon-like Peptide 2 in Rats with Ileal–Jejunal Transposition or Small Bowel Resection
2001
·
Jesper Thulesen
, Bolette Hartmann
, et al.
·
Digestive Diseases and Sciences
·
62
Transgenic Rescue of Adipocyte Glucose-dependent Insulinotropic Polypeptide Receptor Expression Restores High Fat Diet-induced Body Weight Gain
2011
·
Randi Ugleholdt
, Jens Pedersen
, et al.
·
Journal of Biological Chemistry
·
49
Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine
2012
·
Hannelouise Kissow
, Niels-Erik Viby
, et al.
·
Cancer Chemotherapy and Pharmacology
·
48
The Intestinotrophic Peptide, GLP-2, Counteracts Intestinal Atrophy in Mice Induced by the Epidermal Growth Factor Receptor Inhibitor, Gefitinib
2007
·
Kristine Juul Hare
, Bolette Hartmann
, et al.
·
Clinical Cancer Research
·
42
Dynamics of glucagon secretion in mice and rats revealed using a validated sandwich ELISA for small sample volumes
2016
·
Nicolai J. Wewer Albrechtsen
, Rune E. Kuhre
, et al.
·
American Journal of Physiology-Endocrinology and Metabolism
·
39
Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R–dependent manner
2021
·
Sara L. Jepsen
, Nicolai J. Wewer Albrechtsen
, et al.
·
JCI Insight
·
36
PDF
Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice
2018
·
Rasmus Hytting-Andreasen
, Emilie Balk-Møller
, et al.
·
PLoS ONE
·
36
PDF
Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats
2003
·
S.S Poulsen
, J Thulesen
, et al.
·
Regulatory Peptides
·
30
Dietary Fiber Is Essential to Maintain Intestinal Size, L-Cell Secretion, and Intestinal Integrity in Mice
2021
·
Jenna Elizabeth Hunt
, Bolette Hartmann
, et al.
·
Frontiers in Endocrinology
·
27
PDF
Effects of glepaglutide, a long‐acting glucagon‐like peptide‐2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial
2022
·
Rahim M. Naimi
, Mark K. Hvistendahl
, et al.
·
Journal of Parenteral and Enteral Nutrition
·
26
PDF
Bovine Colostrum Modulates Myeloablative Chemotherapy–Induced Gut Toxicity in Piglets
2015
·
Peter EL Pontoppidan
, René L Shen
, et al.
·
Journal of Nutrition
·
25
PDF
Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism
2021
·
Sasha A S Kjeldsen
, Lasse H Hansen
, et al.
·
Journal of the Endocrine Society
·
24
PDF
Show more works
View as search
Works count:
70
Citation count:
2,089
H-index:
24
I10-index:
44
Year
Topic
Type
